
11.90 Delayed Data As of Jun 06 | ![]() Today’s Change | 5.20 Today|||52-Week Range 23.85 | +98.14% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 74.00 and a low estimate of 28.00. The median estimate represents a +152.10% increase from the last price of 11.90.
The current consensus among 3 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.